| Followers | 23 |
| Posts | 14992 |
| Boards Moderated | 0 |
| Alias Born | 01/16/2026 |
Monday, February 02, 2026 4:17:17 PM
Hims & Hers to Announce Fourth Quarter and Full Year 2025 Financial Results on February 23, 2026
February 2, 2026 4:05 PM
Business Wire
Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the leading health and wellness platform, today announced that it will report fourth quarter and full year 2025 financial results after the market closes on Monday, February 23, 2026. The company will host a live conference call to discuss the results at 5:00 p.m. ET the same day.
The conference call can be accessed by dialing (888) 510-2630 for U.S. participants and (646) 960-0137 for international participants, referencing conference ID 1704296. A live audio webcast will be available at https://investors.hims.com and will be archived for one year.
Upcoming Conference Participation
Hims & Hers also announced that members of the company’s management team will be participating in the Morgan Stanley Technology, Media & Telecom Conference on March 2, 2026 in San Francisco.
About Hims & Hers Health, Inc.
Hims & Hers is the leading health and wellness platform on a mission to help the world feel great through the power of better health.
We believe how you feel in your body and mind transforms how you show up in life. That’s why we’re building a future where nothing stands in the way of harnessing this power. Hims & Hers normalizes health & wellness challenges—and innovates on their solutions—to make feeling happy and healthy easy to achieve. No two people are the same, so the Company provides access to personalized care designed for results.
For more information, please visit https://investors.hims.com/.
View source version on businesswire.com: https://www.businesswire.com/news/home/20260202870372/en/
Investor Relations
Bill Newby
Investors@forhims.com
Media Relations
Abby Reisinger-Moley
Press@forhims.com
Original: Hims & Hers to Announce Fourth Quarter and Full Year 2025 Financial Results on February 23, 2026
Recent HIMS News
- Hims & Hers jumps 7% after expanding partnership with Eli Lilly • IH Market News • 04/23/2026 02:06:56 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/22/2026 09:24:12 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/22/2026 09:24:06 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/20/2026 08:38:03 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 04/20/2026 05:19:21 PM
- Hims & Hers Shares Jump on Proposed FDA Peptide Rule Changes • IH Market News • 04/16/2026 11:27:25 AM
- Hims & Hers to Announce First Quarter 2026 Financial Results on May 11, 2026 • Business Wire • 04/13/2026 08:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/10/2026 10:56:39 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/07/2026 09:14:38 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 04/06/2026 10:03:23 PM
- Novo Nordisk’s FDA-Approved GLP-1s Now Available With Hims & Hers • Business Wire • 03/26/2026 04:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/24/2026 10:09:57 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/18/2026 08:17:47 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/18/2026 08:17:40 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/18/2026 08:17:34 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/17/2026 08:29:34 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/17/2026 08:29:28 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/17/2026 08:29:18 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/17/2026 08:29:01 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/17/2026 08:28:52 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/17/2026 08:28:44 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/17/2026 08:28:36 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/17/2026 04:41:34 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/17/2026 03:39:19 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/17/2026 02:06:32 PM
